Research in Microbiology, published by Elsevier, is a prominent academic journal devoted to advancing the field of microbiology, encompassing a diverse array of topics including immunology, molecular biology, and biochemistry. Established in 1987, the journal has expanded its focus over the years, with a commendable impact factor reflecting its relevance and influence in the scientific community. Although it does not currently offer open access options, Research in Microbiology remains a crucial resource for researchers and professionals seeking to stay abreast of the latest findings and methodologies. The journal holds a respectable Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in both Microbiology and Molecular Biology for 2023, highlighting its position within the scholarly landscape. With its base in France and accessible to a global audience, Research in Microbiology continues to foster scholarly exchange, making it an essential platform for the dissemination of impactful microbiological research.

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

Microbial Physiology is a premier, peer-reviewed journal published by KARGER, dedicated to advancing the field of microbiology through innovative research and reviews. With an ISSN of 2673-1665 and an E-ISSN of 2673-1673, the journal stands out in the academic landscape having established a strong track record since its inception in 2020, converging its scope until 2024. It proudly holds a Q2 category ranking in several key areas including Applied Microbiology and Biotechnology, Biochemistry, and Microbiology, making it an essential resource for researchers and professionals in these disciplines. The journal provides open access options to ensure that cutting-edge findings are widely disseminated, fostering collaboration and knowledge sharing. As a vital contributor to the ongoing discourse in microbial physiology, the journal serves as a platform for novel discoveries and methodologies that can significantly impact health, industry, and environmental sustainability. Located in Basel, Switzerland, it brings together a global community of scholars eager to further explore the complexities of microbial life.

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

Current Research in Microbial Sciences is a distinguished peer-reviewed journal published by Elsevier, focusing on the dynamic and rapidly advancing fields of microbiology and infectious diseases. With an ISSN of 2666-5174, this journal has established itself as an essential resource for researchers, professionals, and students alike, offering the latest findings and insights from 2020 to 2024. The journal holds a significant position in the academic landscape, achieving a Q2 ranking across multiple categories, including Immunology and Microbiology, Infectious Diseases, and Medical Microbiology, demonstrating its impact in these critical areas of study. With impressive Scopus rankings—such as being placed in the 94th percentile for Immunology and Microbiology—current research is well-supported by a thriving scientific community. Although the journal is not open access, it serves as a vital platform for disseminating high-quality research and fostering collaboration within the microbial sciences. Engaging with this journal enables professionals and researchers to stay abreast of innovations and contribute to the collective body of knowledge that shapes our understanding of microbial interactions and infectious diseases.

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, published by Springer, serves as a pivotal forum for advancing the fields of microbiology and biotechnology since its inception in 1990. Located in the Netherlands, this esteemed journal has secured a prominent position in the academic landscape, recognized for its strong impact factor and prestigious Q2 category rankings across disciplines such as Applied Microbiology, Biotechnology, and Physiological Sciences. Researchers and professionals utilize this journal to disseminate innovative findings and explore emerging technologies that are transforming the scientific landscape. With a robust submission rate and high visibility among the academic community, the journal fosters interdisciplinary collaboration, encouraging discussions that bridge gaps between theory and practical applications. As it converges into 2024, the WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY continues to be a vital resource for scholars aiming to enhance our understanding of microbial processes and biotechnological advances.

FOLIA MICROBIOLOGICA is a distinguished academic journal published by SPRINGER, focusing on the intricate realms of microbiology and its contributions to medicine. Since its inception in 1957, the journal has been a vital platform for disseminating pioneering research, addressing contemporary challenges in the field while facilitating discourse among researchers, clinicians, and students alike. With an ISSN of 0015-5632 and an E-ISSN of 1874-9356, FOLIA MICROBIOLOGICA publishes original articles, reviews, and critical insights that span not only traditional microbiological studies but also innovative applications in immunology and biotechnology. The journal is categorized within the esteemed Q2 tier in Medicine (Miscellaneous) and holds a Q3 rating in Microbiology as of 2023, reflecting its significant impact and relevance in the scientific community. Although it does not currently offer open access, it remains a respected resource, enabling professionals and students to keep abreast of advancements from its base in the Netherlands. With a strong commitment to quality and rigorous peer-review, FOLIA MICROBIOLOGICA serves as an essential repository of knowledge, fostering the next generation of microbiologists and medical practitioners.

Nature Microbiology is a premier journal published by NATURE PORTFOLIO that has firmly established itself within the realms of microbiological research since its inception in 2016. Based in the United Kingdom, this prestigious journal specializes in the intricacies of applied microbiology, cell biology, genetics, immunology, and medical microbiology, making it a cornerstone for academics and professionals alike. With an impressive Scopus ranking placing it in the top tier across various relevant categories—such as rank #3 in Genetics and #2 in Applied Microbiology—it underscores the journal’s commitment to high-quality, impactful research. Although it operates under a subscription model, Nature Microbiology's broad Open Access policy facilitates greater dissemination and visibility for its authors. The journal's objectives are centered around publishing cutting-edge advancements that enhance our understanding of microbial life, its interactions, and applications in health and disease. As a Q1 journal across multiple disciplines, it holds immense significance for researchers, professionals, and students enthusiastic about the latest innovations and breakthroughs in microbiology.

Microbiology Australia is a prominent journal published by CSIRO PUBLISHING, focusing on the diverse and rapidly evolving field of microbiology. Since its transition to Open Access in 2021, it has broadened its accessibility, fostering greater dissemination of research findings among scholars and practitioners. The journal features a range of topics that are pivotal for understanding microbial systems in applied microbiology, medical microbiology, public health, and environmental applications. Despite its current categorization in the Q4 quartile across several categories, it remains an essential platform for emerging research and innovative methodologies. Researchers and professionals can benefit from the journal's commitment to enriching the global discourse on microbiological advancements. With its ISSN 1324-4272 and E-ISSN 2201-9189, Microbiology Australia caters to a wide audience in Australia and beyond, making significant strides in bridging the gap between research and practical applications in microbiology.

mBio is a premier, peer-reviewed open-access journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology and virology. With an impressive impact factor and a commendable standing within the top quartiles (Q1) of both microbiology and virology categories as of 2023, mBio offers a dynamic platform for researchers and professionals to disseminate high-quality, rigorous scientific findings. Since its inception in 2010, it has served as a vital resource for the global scientific community, facilitating open access to groundbreaking research that spans diverse topics within microbiology. With a Scopus ranking of #28 out of 182 in Microbiology and #16 out of 80 in Virology, mBio significantly influences ongoing research trends and informs best practices in the field. Its commitment to open-access publishing allows for widespread visibility and accessibility, ensuring that critical discoveries reach a broad audience, including students and academics eager to contribute to, and learn from, cutting-edge science.